ES2132330T3 - Vacuna para la proteccion de caballos frente a la infeccion por el virus del herpes equino. - Google Patents

Vacuna para la proteccion de caballos frente a la infeccion por el virus del herpes equino.

Info

Publication number
ES2132330T3
ES2132330T3 ES94203641T ES94203641T ES2132330T3 ES 2132330 T3 ES2132330 T3 ES 2132330T3 ES 94203641 T ES94203641 T ES 94203641T ES 94203641 T ES94203641 T ES 94203641T ES 2132330 T3 ES2132330 T3 ES 2132330T3
Authority
ES
Spain
Prior art keywords
vaccine
protection
herpes virus
against infection
equine herpes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94203641T
Other languages
English (en)
Inventor
Martha Jacoba Willemse
Paulus Jacobus An Sondermeijer
Lesley Nickolson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2132330T3 publication Critical patent/ES2132330T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA VACUNA HERPESVIRUS EQUINA (EHV) COMPRENDIENDO UNA EHV QUE TIENE UNA INSERCION O SUPRESION EN EL GEN 15 DEL GENOMA DE LA EHV.
ES94203641T 1993-12-20 1994-12-15 Vacuna para la proteccion de caballos frente a la infeccion por el virus del herpes equino. Expired - Lifetime ES2132330T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93203584 1993-12-20

Publications (1)

Publication Number Publication Date
ES2132330T3 true ES2132330T3 (es) 1999-08-16

Family

ID=8214224

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94203641T Expired - Lifetime ES2132330T3 (es) 1993-12-20 1994-12-15 Vacuna para la proteccion de caballos frente a la infeccion por el virus del herpes equino.

Country Status (5)

Country Link
US (1) US5674499A (es)
JP (1) JP3710838B2 (es)
AT (1) ATE178654T1 (es)
DE (1) DE69417717T2 (es)
ES (1) ES2132330T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
EP1151124A1 (en) * 1999-02-03 2001-11-07 The Children's Medical Center Corporation Gene repair involving in vivo excision of targeting dna
EP1147209A2 (en) * 1999-02-03 2001-10-24 The Children's Medical Center Corporation Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
EP1394258A1 (en) * 2002-08-30 2004-03-03 Geneart GmbH Non-human herpesviruses as vectors
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
CA2867893C (en) * 2012-03-20 2022-09-20 Merial Limited Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014951D0 (en) * 1990-07-06 1990-08-29 Univ Glasgow Equine herpesvirus-4 tk vaccine

Also Published As

Publication number Publication date
DE69417717T2 (de) 1999-10-07
DE69417717D1 (de) 1999-05-12
ATE178654T1 (de) 1999-04-15
JPH07236489A (ja) 1995-09-12
JP3710838B2 (ja) 2005-10-26
US5674499A (en) 1997-10-07

Similar Documents

Publication Publication Date Title
BR9812232A (pt) Vìrus sincicial respiratório (rsv) humano subgrupo b, isolado, recombinantemente gerado , atenuado, vacina, processo para imunizar um indivìduo para induzir proteção contra o rsv subgrupo b, composição, processo para produzir rsv subgrupo b infeccioso atenuado, e, molécula isolada de ácido nucleico
ES2035818T3 (es) Mutantes de delecion de la timidin-kinasa del virus del herpes bovino-1, vacunas contra la rinotraqueitis bovina infecciosa que los contienen y metodos para su produccion y uso.
ATE420190T1 (de) Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
BR9712138A (pt) Vìrus de rna isolado, vacina, processo para imunizr um indivìduo para induzir proteção contra um vìrus de rna não segmentado, sentido negativo, de filamento único, da ordem mononegavirales e para produzir vìrus de rna, molécula de ácido nucleico isolada e composição.
AU585126B2 (en) Recombinant herpes simplex viruses, vaccines and methods
ATE138384T1 (de) Olionukleotidalkylphosphonate und - phosphonothioate
ES2143507T3 (es) Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia.
UA40571C2 (uk) Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена
ATE79548T1 (de) Herpes simplex virus subunitimpfstoff.
BR9202024A (pt) Virus de apivox recombinante,cultura de celulas eucariotica infectadas por um virus de avipox,vacina,sequencia de transferencia e plasmideo
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
ATE118353T1 (de) Rekombinanter herpes simplex gb-gd impfstoff.
MY103575A (en) Cannie coronavirus vaccine
ES2132330T3 (es) Vacuna para la proteccion de caballos frente a la infeccion por el virus del herpes equino.
ES2113348T3 (es) Composiciones de vacunas estabilizadas.
BR0316244A (pt) Vacina de polinucleotìdeo, métodos de prevenção ou de tratamento de uma infecção por hcv em um mamìfero e de vacinação de um indivìduo, e, uso de uma vacina de polinucleotìdeo
ES2141093T3 (es) Herpesvirus equinos (ehv) que contienen adn ajeno, procedimiento para su obtencion y su empleo en vacunas.
ES2146214T3 (es) Vacunas para actinobacillus pleuropneumoniae.
ITMI913092A1 (it) Vaccino di poxvirus ricombinante del virus del morbillo
AR005750A1 (es) Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion
HUP0102861A2 (hu) Attenuált lóherpeszvírus
GB2359083A (en) Mutant herpes simplex viruses and uses thereof
DE69226980D1 (de) Rekombinanter Varicella-Zoster-Virus-Vektor
ES2061165T3 (es) Vacuna para la proteccion de las aves de corral frente a la enfermedad de marek.
BR9304911A (pt) Vacina, composiçao virotica liofilizada, processo para proteçao de aves domésticas e processo para preparaçao de vacina viva.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 668355

Country of ref document: ES